BETSY ABRAHAM: Open Payments
NPI 1346767373 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 7 payments from 6 companies in 2025. Trend: 2023 $36 · 2024 $343 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| Stemline Therapeutics Inc. | 1 | $111 |
| Gilead Sciences, Inc. | 1 | $89 |
| Merck Sharp & Dohme LLC | 1 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: DATROWAY, Nubeqa, Orserdu, Trodelvy, KEYTRUDA, ENTYVIO.
Industry payments across TX — which companies pay providers there.
